A staff member of BIOR, Latvia’s Institute of Food Safety, Animal Health and Environment, operates smart automated DNA extraction equipment provided by China's MGI Tech Co., Ltd. in Riga, Latvia (Photo by Janis/Xinhua) RIGA, Feb. 15 (Xinhua) -- Since the outbreak of the coronavirus epidemic in Latvia, Chinese companies have been helping the Baltic country to fight COVID-19 by supplying equipment for automated sample extraction and gene sequencing. When the second COVID-19 wave hit Latvia...

STOCKHOLM, Feb. 10, 2021 -- MGI Tech Co., Ltd. ("MGI")'s high-throughput gene sequencer has helped the regions throughout Sweden greatly improve their COVID-19 testing capabilities from the laboratory at the National Pandemic Center located in Karolinska Institute (KI). Sweden's STV News, the national public television, recently reports that only one percent (1%) of the positive COVID-19 samples have been currently sequenced in Sweden and main regions in the country have been commissioned...

The pandemic has recently been spreading rapidly across the world, posing a formidable challenge to global public health security. The current epidemic situation is still grim and complex. As an important measure for the COVID-19 prevention and control, how to improve the capacity of nucleic acid detection has attracted great attention from all countries. As reported on LSM.lv Latvia’s national television, Scientific institute ‘Bior’, which is one of the Covid-19 testing labs in Latvia...

Recently, MGI and Annoroad formally announced their strategic cooperation on the development of domestic sequencing platform applications. According to the cooperation, Annoroad will join hands with MGI to develop sequencing applications based on DNBSEQ-T7 ultra-high throughput sequencing platform and promote the R&D and commercialization in life sciences. As a leading player in the high-throughput sequencing industry, Annoroad has accumulated extensive experience in scientific research ...

In response to an article in the Daily Telegraph published on February 6, MGI would like to point out the following: 1. The article makes factually inaccurate claims. MGI does not produce PCR testing equipment. Also, the NHS and MGI do not have a partnership. 2. As the article itself states, “MGI is not accused of collecting or misusing any genetic data”. We have never collected or misused any genetic data in any of the markets in which we operate, and MGI strenuously rejects any suggestions...

SHENZHEN, China, Feb 7, 2021-- Shenzhen Life Science and Technology University-Industry-Institute Alliance released the industry’s first “Specifications of Remote Robotic Ultrasound Systems for COVID-19 Diagnosis”, (referred to as the Specifications), providing technical references for institutions applying robotic ultrasound diagnosis in COVID-19 diagnosis. The First Specifications of Remote Robotic Ultrasound Systems for COVID-19 Diagnosis Compared with the traditional ultrasound e...